JP2007505158A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007505158A5 JP2007505158A5 JP2006533221A JP2006533221A JP2007505158A5 JP 2007505158 A5 JP2007505158 A5 JP 2007505158A5 JP 2006533221 A JP2006533221 A JP 2006533221A JP 2006533221 A JP2006533221 A JP 2006533221A JP 2007505158 A5 JP2007505158 A5 JP 2007505158A5
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US47229803P | 2003-05-21 | 2003-05-21 | |
| PCT/US2004/015715 WO2004112763A2 (en) | 2003-05-21 | 2004-05-19 | Inhibition of protein kinase c-mu (pkd) as a treatment for cardiac hypertrophy and heart failure |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2007505158A JP2007505158A (ja) | 2007-03-08 |
| JP2007505158A5 true JP2007505158A5 (enExample) | 2007-11-08 |
Family
ID=33539040
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006533221A Pending JP2007505158A (ja) | 2003-05-21 | 2004-05-19 | 心肥大および心不全の処置としてのプロテインキナーゼＣ−μ（ＰＫＤ）の阻害 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20050112128A1 (enExample) |
| EP (1) | EP1631268A2 (enExample) |
| JP (1) | JP2007505158A (enExample) |
| CN (1) | CN1812776A (enExample) |
| AU (1) | AU2004249114A1 (enExample) |
| BR (1) | BRPI0410787A (enExample) |
| CA (1) | CA2526423A1 (enExample) |
| MX (1) | MXPA05012619A (enExample) |
| WO (1) | WO2004112763A2 (enExample) |
Families Citing this family (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7154002B1 (en) | 2002-10-08 | 2006-12-26 | Takeda San Diego, Inc. | Histone deacetylase inhibitors |
| KR20050122210A (ko) | 2003-03-17 | 2005-12-28 | 다케다 샌디에고, 인코포레이티드 | 히스톤 탈아세틸화 효소 억제제 |
| WO2005018673A1 (en) * | 2003-08-21 | 2005-03-03 | Osaka University | Pharmaceutical composition for preventing or remedying cardiac hypertrophy and cardiocascular disease caused thereby |
| WO2006060196A2 (en) * | 2004-12-02 | 2006-06-08 | The Trustees Of Columbia University In The City Of New York | Use of rottlerin and its derivatives as activators of bk channel for therapy of hypertension and related disorders |
| JP2008524246A (ja) | 2004-12-16 | 2008-07-10 | タケダ サン ディエゴ インコーポレイテッド | ヒストンデアセチラーゼ阻害剤 |
| WO2006122319A2 (en) | 2005-05-11 | 2006-11-16 | Takeda San Diego, Inc. | Histone deacetylase inhibitors |
| ZA200800901B (en) | 2005-07-14 | 2010-05-26 | Takeda San Diego Inc | Histone deacetylase inhibitors |
| EP1760092A1 (en) * | 2005-08-26 | 2007-03-07 | Applied Research Systems ARS Holding N.V. | System for screening cells for high expression of a protein of interest |
| WO2007084857A2 (en) * | 2006-01-13 | 2007-07-26 | President And Fellows Of Harvard College | Methods and compositions for treating cell proliferative disorders |
| KR20080108156A (ko) * | 2006-04-06 | 2008-12-11 | 노파르티스 아게 | 유기 화합물의 조합물 |
| US9580515B2 (en) * | 2006-08-21 | 2017-02-28 | Zensun (Shanghai) Science & Technology, Co., Ltd. | Neukinase, a downstream protein of neuregulin |
| CN101917999A (zh) * | 2007-11-07 | 2010-12-15 | 弗尔德里克斯制药股份有限公司 | 蛋白质运输的调节 |
| GB0810051D0 (en) * | 2008-06-02 | 2008-07-09 | Oxford Biodynamics Ltd | Method of diagnosis |
| WO2013053076A1 (en) | 2011-10-10 | 2013-04-18 | Zensun （Shanghai）Science & Technology Limited | Compositions and methods for treating heart failure |
| CA2856030A1 (en) | 2011-11-16 | 2013-05-23 | Duke University | Bisphosphonate compositions and methods for treating and/or reducing cardiac dysfunction |
| US9132174B2 (en) | 2013-03-15 | 2015-09-15 | Anchored Rsk3 Inhibitors, Llc | Treatment of heart disease by inhibition of the action of ribosomal S6 kinase 3 (RSK3) |
| EP2999499B1 (en) | 2013-05-22 | 2019-07-17 | Zensun (Shanghai) Science & Technology, Co., Ltd. | Extended release of neuregulin for treating heart failure |
| CN104558114B (zh) * | 2013-10-21 | 2018-06-08 | 中国科学院大连化学物理研究所 | 花粉中具有ace抑制活性的多肽及其应用 |
| CN104558110B (zh) * | 2013-10-21 | 2018-06-08 | 中国科学院大连化学物理研究所 | 具有ace抑制活性的多肽及其在降血压药物中的应用 |
| CA2932787A1 (en) * | 2013-12-06 | 2015-06-11 | Novimmune S.A. | Anti-tlr4 antibodies and methods of use thereof |
| CN104758922A (zh) | 2014-01-03 | 2015-07-08 | 上海泽生科技开发有限公司 | 纽兰格林制剂的配方 |
| US9730916B2 (en) * | 2014-02-27 | 2017-08-15 | Chang Gung Memorial Hospital, Keelung | Nutritional composition and method for improving heart failure |
| GB2527364A (en) * | 2014-06-20 | 2015-12-23 | Imp Innovations Ltd | Treatment |
| CN111407882A (zh) | 2014-10-17 | 2020-07-14 | 上海泽生科技开发股份有限公司 | 神经调节蛋白用于预防、治疗或延迟射血分数保留的心力衰竭的方法和组合物 |
| CR20170566A (es) * | 2015-06-09 | 2018-03-20 | Bayer Pharma AG | Moduladores alostéricos positivos del receptor muscarínico m2 |
| WO2019010301A1 (en) * | 2017-07-06 | 2019-01-10 | Kapiloff Michael S | TREATMENT OF CARDIOPATHIES BY INHIBITING THE ACTION OF PROTEINS FROM ANCHORING TO MUSCLE PROTEIN KINASES A (MAKAP) |
| CN107811997A (zh) * | 2017-11-10 | 2018-03-20 | 大连医科大学附属第医院 | 蛋白酶体抑制剂白藜芦醇在预防和治疗心血管疾病中的应用 |
| CN108379585B (zh) * | 2018-04-16 | 2020-10-16 | 复旦大学附属中山医院 | Hdac4抑制剂在制备治疗心力衰竭的药物中的应用 |
| EP3811451A4 (en) * | 2018-05-23 | 2022-04-06 | University of Pittsburgh - of the Commonwealth System of Higher Education | HEART SPECIFIC TARGETING PEPTIDE (CTP), COMPOSITIONS AND USES THEREOF |
| JP2022500422A (ja) * | 2018-09-18 | 2022-01-04 | ソシエテ・デ・プロデュイ・ネスレ・エス・アー | 骨格筋調節のためのｓｒｃ阻害剤化合物、それらの方法及び使用 |
| CN109321602B (zh) * | 2018-10-16 | 2021-11-30 | 汉恒生物科技（上海）有限公司 | Pkd2重组过表达载体及其构建方法和用途 |
| US11938198B2 (en) | 2019-05-15 | 2024-03-26 | University Of Miami | Treatment of heart disease by disruption of the anchoring of PP2A |
| CN112451529A (zh) * | 2020-12-18 | 2021-03-09 | 忻佑康医药科技(南京)有限公司 | Kb-NB 142-70的药物新用途 |
| JP2024516730A (ja) * | 2021-05-04 | 2024-04-16 | エナラーレ セラピューティクス インコーポレイテッド | 大導電性カリウムチャネル調節剤、その組成物、その製造方法、及びその使用方法 |
| CN116942822A (zh) * | 2023-06-12 | 2023-10-27 | 深圳大学 | Hdac2在治疗室性心律失常中的应用 |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4196265A (en) * | 1977-06-15 | 1980-04-01 | The Wistar Institute | Method of producing antibodies |
| US4458066A (en) * | 1980-02-29 | 1984-07-03 | University Patents, Inc. | Process for preparing polynucleotides |
| US4873191A (en) * | 1981-06-12 | 1989-10-10 | Ohio University | Genetic transformation of zygotes |
| US4415723A (en) * | 1982-03-19 | 1983-11-15 | General Electric Company | Randomly branched aromatic polycarbonate from triphenol |
| US5955501A (en) * | 1986-06-11 | 1999-09-21 | Procyon Pharmaceuticals, Inc. | Protein kinase C modulators O |
| US6080784A (en) * | 1986-06-11 | 2000-06-27 | Procyon Pharmaceuticals, Inc. | Protein kinase C modulators N |
| US6043270A (en) * | 1986-06-11 | 2000-03-28 | Procyon Pharmaceuticals, Inc. | Protein kinase C modulators V |
| US4987071A (en) * | 1986-12-03 | 1991-01-22 | University Patents, Inc. | RNA ribozyme polymerases, dephosphorylases, restriction endoribonucleases and methods |
| FR2685346B1 (fr) * | 1991-12-18 | 1994-02-11 | Cis Bio International | Procede de preparation d'arn double-brin, et ses applications. |
| TW215434B (enExample) * | 1992-03-07 | 1993-11-01 | Hoechst Ag | |
| US5889136A (en) * | 1995-06-09 | 1999-03-30 | The Regents Of The University Of Colorado | Orthoester protecting groups in RNA synthesis |
| WO1997015575A1 (en) * | 1995-10-27 | 1997-05-01 | Procyon Pharmaceuticals, Inc. | Protein kinase c modulators. y. |
| US6228843B1 (en) * | 1999-04-23 | 2001-05-08 | University Technology Corporation | Method of using PKC inhibiting compounds to treat vascular disease |
| US6372468B1 (en) * | 2000-09-14 | 2002-04-16 | Pe Corporation (Ny) | Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| US20030134774A1 (en) * | 2001-06-15 | 2003-07-17 | Steinberg Susan F. | Methods for inhibiting cardiac disorders |
| US6706686B2 (en) * | 2001-09-27 | 2004-03-16 | The Regents Of The University Of Colorado | Inhibition of histone deacetylase as a treatment for cardiac hypertrophy |
| AU2003222513A1 (en) * | 2002-03-08 | 2003-09-22 | Protemix Corporation Limited | Preventing and/or treating vascular disease, cardiomyopathy and/or associated heart failure |
| US20030229030A1 (en) * | 2002-06-11 | 2003-12-11 | Theoharides Theoharis C. | Method of treating interleukin-6-mediated inflammatory diseases |
| EP1546369A4 (en) * | 2002-08-12 | 2007-01-17 | Univ Michigan | DIAGNOSIS AND TREATMENT OF DISEASES THROUGH DEFECTS IN THE TUBEROUS SKLEROSEPFAD |
| WO2004017957A1 (en) * | 2002-08-20 | 2004-03-04 | Protemix Corporation Limited | Preventing and/or treating cardiovascular disease and/or associated heart failure |
-
2004
- 2004-05-19 MX MXPA05012619A patent/MXPA05012619A/es not_active Application Discontinuation
- 2004-05-19 CA CA002526423A patent/CA2526423A1/en not_active Abandoned
- 2004-05-19 WO PCT/US2004/015715 patent/WO2004112763A2/en not_active Ceased
- 2004-05-19 US US10/848,820 patent/US20050112128A1/en not_active Abandoned
- 2004-05-19 CN CNA2004800139983A patent/CN1812776A/zh active Pending
- 2004-05-19 EP EP04752691A patent/EP1631268A2/en not_active Withdrawn
- 2004-05-19 JP JP2006533221A patent/JP2007505158A/ja active Pending
- 2004-05-19 BR BRPI0410787-0A patent/BRPI0410787A/pt not_active IP Right Cessation
- 2004-05-19 AU AU2004249114A patent/AU2004249114A1/en not_active Abandoned